Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2009 1
2010 1
2016 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Analgesic Effects of 5-Alkyloxy-4-amino-2(5H)-furanones as Cholecystokinin-2 Antagonists.
Lattmann E, Sattayasai J, Schwalbe CH, Boonprakob Y, Dunn S, Fajana F, Lattmann P. Lattmann E, et al. Among authors: lattmann p. Arch Pharm (Weinheim). 2016 Jun;349(6):456-65. doi: 10.1002/ardp.201600036. Epub 2016 May 3. Arch Pharm (Weinheim). 2016. PMID: 27142294
Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action.
Ponnusamy S, Lattmann E, Lattmann P, Thiyagarajan T, Padinjarethalakal BN, Narayanan R. Ponnusamy S, et al. Among authors: lattmann p. Oncol Rep. 2016 Apr;35(4):2097-106. doi: 10.3892/or.2016.4588. Epub 2016 Jan 22. Oncol Rep. 2016. PMID: 26820391
Synthesis and evaluation of N-(3-oxo-2,3-dihydro-1H-pyrazol-4-yl)-1H-indole-carboxamides as cholecystokinin antagonists.
Lattmann E, Singh H, Boonprakob Y, Lattmann P, Sattayasai J. Lattmann E, et al. Among authors: lattmann p. J Pharm Pharmacol. 2006 Mar;58(3):393-401. doi: 10.1211/jpp.58.3.0015. J Pharm Pharmacol. 2006. PMID: 16536908
In vivo evaluation of substituted 3-amino-1,4-benzodiazepines as anti-depressant, anxiolytic and anti-nociceptive agents.
Lattmann E, Lattmann P, Boonprakob Y, Airarat W, Singh H, Offel M, Sattayasai J. Lattmann E, et al. Among authors: lattmann p. Arzneimittelforschung. 2009;59(2):61-71. doi: 10.1055/s-0031-1296366. Arzneimittelforschung. 2009. PMID: 19338136
Antidepressant/anxiolytic and anti-nociceptive effects of novel 2-substituted 1,4-benzodiazepine-2-ones.
Singh H, Sattayasai J, Lattmann P, Boonprakob Y, Lattmann E. Singh H, et al. Among authors: lattmann p. Sci Pharm. 2010 Apr-Jun;78(2):155-69. doi: 10.3797/scipharm.1004-12. Epub 2010 May 17. Sci Pharm. 2010. PMID: 21179341 Free PMC article.
Synthesis and evaluation of N-(5-methyl-3-oxo-1,2- diphenyl-2,3-dihydro-1H-pyrazol-4-yl)-N'-phenylureas as cholecystokinin antagonists.
Lattmann E, Sattayasai J, Boonprakob Y, Lattmann P, Singh H. Lattmann E, et al. Among authors: lattmann p. Arzneimittelforschung. 2005;55(5):251-8. doi: 10.1055/s-0031-1296853. Arzneimittelforschung. 2005. PMID: 15960423
Novel anti-bacterials against MRSA: synthesis of focussed combinatorial libraries of tri-substituted 2(5H)-furanones.
Lattmann E, Sattayasai N, Schwalbe CS, Niamsanit S, Billington DC, Lattmann P, Langley CA, Singh H, Dunn S. Lattmann E, et al. Among authors: lattmann p. Curr Drug Discov Technol. 2006 Jun;3(2):125-34. doi: 10.2174/157016306778108857. Curr Drug Discov Technol. 2006. PMID: 16925520
Synthesis of substituted 3-anilino-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepine-2-ones and their evaluation as cholecystokinin-ligands.
Offel M, Lattmann P, Singh H, Billington DC, Bunprakob Y, Sattayasai J, Lattmann E. Offel M, et al. Among authors: lattmann p. Arch Pharm (Weinheim). 2006 Apr;339(4):163-73. doi: 10.1002/ardp.200500217. Arch Pharm (Weinheim). 2006. PMID: 16572480